Role of Chest Computed Tomography in the Early Diagnosis and Assessment of Pulmonary Tuberculosis
International Journal of Medicine · 26.06.2026 · 8 (6) · 1675-1682
DOI: 10.61336/im/26-06-246 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medicine, online erschienen am 26.06.2026.
Abstract (Originalsprache)
Background
Pulmonary tuberculosis (PTB) remains a leading infectious cause of morbidity and mortality worldwide. While conventional chest radiography (CXR) and sputum smear microscopy are the cornerstones of initial screening, they suffer from significant limitations in sensitivity, particularly in early, atypical, or smear-negative cases. High-resolution computed tomography (HRCT) of the chest has emerged as a critical adjunctive tool, yet its precise diagnostic yield and role in early disease assessment require further clinical validation.
Objective
To evaluate the diagnostic accuracy, pattern recognition, and clinical utility of HRCT in the early diagnosis and severity assessment of PTB, particularly in smear-negative patients.
Methods
A prospective observational cohort study was conducted at a tertiary care center from June 2025 to May 2026. We enrolled 412 adult patients presenting with clinical suspicion of PTB. All patients underwent standard CXR, non-contrast chest HRCT, sputum smear microscopy, GeneXpert MTB/RIF assay, and mycobacterial culture. Diagnostic performance of HRCT was compared against the composite microbiological reference standard.
Results
Of the 412 suspected cases, 260 (63.1%) were confirmed as active PTB. HRCT demonstrated a sensitivity of 95.3% and a specificity of 88.1%, significantly outperforming CXR (sensitivity 73.4%, specificity 69.7%; p < 0.001). In the smear-negative, culture-positive subgroup (n=110), HRCT successfully identified active disease patterns in 102 patients (92.7%). The most frequent HRCT findings in active PTB were centrilobular nodules (86.1%), "tree-in-bud" appearance (79.2%), and early consolidation (65.3%). Inter-observer agreement for HRCT interpretation was excellent (Κ = 0.88). Furthermore, HRCT accurately mapped disease extent and identified occult complications, such as micro-cavitations and early bronchiectasis, missed by conventional radiography.
Conclusion
Chest CT is a highly sensitive and specific modality for the early diagnosis of pulmonary tuberculosis. It is exceptionally valuable in evaluating sputum smear-negative patients and characterizing the anatomical extent of the disease. Integrating HRCT into standard diagnostic algorithms for high-suspicion, smear-negative cases can significantly reduce diagnostic delays and curb transmission.
Zitieren
APA
(2026). Role of Chest Computed Tomography in the Early Diagnosis and Assessment of Pulmonary Tuberculosis. International Journal of Medicine, 8(6), 1675-1682. https://doi.org/10.61336/im/26-06-246
Vancouver
Role of Chest Computed Tomography in the Early Diagnosis and Assessment of Pulmonary Tuberculosis. International Journal of Medicine. 2026;8(6):1675-1682. doi:10.61336/im/26-06-246
BibTeX
@article{euvimed2026,
title = {Role of Chest Computed Tomography in the Early Diagnosis and Assessment of Pulmonary Tuberculosis},
journal = {International Journal of Medicine},
year = {2026},
volume = {8},
number = {6},
pages = {1675--1682},
doi = {10.61336/im/26-06-246}
}
EUVIMED